SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-297974
Filing Date
2017-09-28
Accepted
2017-09-28 17:18:08
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B4 d401686d424b4.htm 424B4 1776054
2 GRAPHIC g401686g08t62.jpg GRAPHIC 46312
3 GRAPHIC g401686g14x63.jpg GRAPHIC 58492
4 GRAPHIC g401686g31s98.jpg GRAPHIC 30888
5 GRAPHIC g401686g35n93.jpg GRAPHIC 57239
6 GRAPHIC g401686g49n96.jpg GRAPHIC 109146
7 GRAPHIC g401686g55c83.jpg GRAPHIC 64097
  Complete submission text file 0001193125-17-297974.txt   2282314
Mailing Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421
Business Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421 646-522-8445
Nightstar Therapeutics plc (Filer) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-220289 | Film No.: 171108370
SIC: 2836 Biological Products, (No Diagnostic Substances)